Health Condition 1: L918- Other hypertrophic disorders of the skin
Conditions
Interventions
Intervention1: intense pulse light therapy and intralesional steroids: Intense pulse light(530nm and 640nm filter) topically and
intralesional steroids (40mg/ml)subcutaneous
maximum 6 sittings at 4 w
Sponsors
DrULavanya
Eligibility
Inclusion criteria
Inclusion criteria: All clinically diagnosed cases of keloid . Patients who are willing to give informed consent.
Exclusion criteria
Exclusion criteria: Before starting the study - Patients who are pregnant or lactating. Patients planning for pregnancy. Patients with history of intake of oral retinoids in the past 6 months. Patients with signs of active infection or lesions suspicious of malignancy. Patients with diseases or genetic conditions causing photosensitivity or tending to aggravate after light exposure. Patients with co-morbidities- DM,SHT,TB,CAD,EPILEPSY,BA. Patients on Photosensitizing drugs,immunosuppressive drugs,anti coagulants. Bleeding and coagulation disorders,HIV. During Study - If patient develops severe side effects like ulceration / intolerance to pain during the treatment. If patient wants alternate treatment during the study. If patient wants to discontinue the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The end point will be the evaluation of clinical response to both the mode of treatment at 36 weeks after treatment initiation Responses in between the study will be noticed recorded using Modified Vancouver Scar Scale(MVSS) Physicians Global Assessment (PGA) scale Patients overall satisfaction scoreTimepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety profileTimepoint: 36 weeks | — |
Countries
India
Contacts
Public ContactDrULAVANYA
Government Chengalpattu Medical college and hospital
Outcome results
None listed